Deborah Schrag
Impact in
- Oncology top 0.05%
- Colorectal Cancer Surgical Treatments
- Cancer survivorship and care
- Colorectal Cancer Treatments and Studies
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 154
- Colorectal Cancer Surgical Treatments 51
- Cancer survivorship and care 34
- Colorectal Cancer Treatments and Studies 24
- Global Cancer Incidence and Screening 23
-
- Cancer Genomics and Diagnostics 26
- Co-authors
- Peter Brian Bach (27 shared papers)Leah H. Biller (2 shared papers)Joan L. Warren (16 shared papers)Katherine S. Panageas (17 shared papers)Alexia E. Iasonos (5 shared papers)Ethan Basch (37 shared papers)Colin B. Begg (12 shared papers)Ganesh V. Raj (1 shared paper)
- Journals
- Journal of Clinical Oncology (53 papers)JNCI Journal of the National Cancer Institute (31 papers)JAMA (23 papers)Cancer (20 papers)Medical Care (14 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Deborah Schrag
401 papers receiving 51.2k citations
Deborah Schrag's Hit Papers
Peers
Comparison fields: 5 of 202
- Oncology 17.9k
- Cancer Research 4.6k
- Pulmonary and Respiratory Medicine 7.5k
- Pathology and Forensic Medicine 3.1k
- Economics and Econometrics 4.9k
Countries citing papers authored by Deborah Schrag
This map shows the geographic impact of Deborah Schrag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Schrag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Schrag more than expected).
Fields of papers citing papers by Deborah Schrag
This network shows the impact of papers produced by Deborah Schrag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Schrag. The network helps show where Deborah Schrag may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Schrag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 414 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | How To Build and Interpret a Nomogram for Cancer Prognosis Hit paper breakdown → | 2008 | 2433 |
| 2 | Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial Hit paper breakdown → | 2015 | 1952 |
| 3 | Diagnosis and Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2021 | 1894 |
| 4 | Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment Hit paper breakdown → | 2017 | 1658 |
| 5 | Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Hit paper breakdown → | 2002 | 1609 |
| 6 | AACR Project GENIE: Powering Precision Medicine through an International Consortium Hit paper breakdown → | 2017 | 1437 |
| 7 | American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon Cancer Hit paper breakdown → | 2004 | 1180 |
| 8 | The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience Hit paper breakdown → | 2013 | 933 |
| 9 | Patients' Expectations about Effects of Chemotherapy for Advanced Cancer Hit paper breakdown → | 2012 | 923 |
| 10 | Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry Hit paper breakdown → | 2005 | 921 |
| 11 | Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Hit paper breakdown → | 2014 | 897 |
| 12 | Primary Care Physicians Who Treat Blacks and Whites Hit paper breakdown → | 2004 | 852 |
| 13 | Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Hit paper breakdown → | 2015 | 826 |
| 14 | Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment Hit paper breakdown → | 2005 | 812 |
| 15 | American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options Hit paper breakdown → | 2015 | 775 |
| 16 | Overview of the SEER-Medicare Data Hit paper breakdown → | 2002 | 732 |
| 17 | Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303) Hit paper breakdown → | 2010 | 728 |
| 18 | Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer Hit paper breakdown → | 2017 | 711 |
| 19 | Variations in Morbidity after Radical Prostatectomy Hit paper breakdown → | 2002 | 702 |
| 20 | The Influence of Hospital Volume on Survival after Resection for Lung Cancer Hit paper breakdown → | 2001 | 610 |
About Deborah Schrag
Deborah Schrag is a scholar working on Oncology, Cancer Research, Economics and Econometrics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 414 papers that have together received 52.7k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (51 papers), Economic and Financial Impacts of Cancer (36 papers), Cancer survivorship and care (34 papers), Cancer Genomics and Diagnostics (26 papers), Health Systems, Economic Evaluations, Quality of Life (26 papers), Colorectal Cancer Treatments and Studies (24 papers), Global Cancer Incidence and Screening (23 papers) and Palliative Care and End-of-Life Issues (16 papers). The work is most often cited by research in Oncology (17.9k citations), Cancer Research (4.6k citations), Pulmonary and Respiratory Medicine (7.5k citations), Pathology and Forensic Medicine (3.1k citations) and Economics and Econometrics (4.9k citations). Deborah Schrag has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Peter Brian Bach, Leah H. Biller, Joan L. Warren, Katherine S. Panageas, Alexia E. Iasonos, Ethan Basch, Colin B. Begg, Ganesh V. Raj, Carrie N. Klabunde and Mark G. Kris. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute, JAMA, Cancer and Medical Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.